Trials involving Multiple Types of Cancer

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
(CCTG) IND.238A Phase II Study of Durvalumab Retreatment in Patients who Discontinued Prior Checkpoint Therapy Due to Immune Related ToxicityDr Peter EllisOpen to recruitmentNCT03847649
(Takeda) TAK-676-1002An Open-label, Dose Escalation, Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-676 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced or Metastatic Solid TumorsDr Brandon MeyersSuspended/On holdNCT04420884
(Bold Therapeutics) BOLD-100-001 / TRIO039A Phase 1b Dose Escalation Study of BOLD-100 in Combination with FOLFOX Chemotherapy in Patients with Advanced Solid TumoursDr Elaine McWhirterOpen to recruitmentNCT04421820
Download PDF